From: Transsplenic tract closure after transsplenic portalvenous access using gelfoam-based tract plugging
Patient characteristics | |
 Number of patients | 24 |
 Age (years) | 56 (29;71) |
 Gender (male / female) | 11 / 13 |
 Liver disease (cirrhotic / non-cirrhotic) | 15 / 9 |
  Ethyltoxic liver cirrhosis | 8 |
  Cryptogenic liver cirrhosis | 1 |
  Liver fibrosis | 1 |
  SCC | 1 |
  Post-LTx | 1 |
  PVT | 4 |
  CTPV | 3 |
  CCC | 3 |
  PCA | 1 |
  FNH | 1 |
Pre-interventional characteristics | |
 Number of interventions | 26 |
 MELD | 9 (6;25) |
 INR | 1.15 (0.86;1.51) |
 aPTT (s) | 33 (26;52) |
 PLT (1*100/uL) | 88 (31;273) |
 Anti-aggregation or -coagulation pre-interventionally (no. of patients) | 10 |
 Transfusion pre-interventionally (no. of patients) | 7 |
 Ascites pre-interventionally (present / none) | 20 / 6 |
 Spleen diameter (cm) | 17 (10;25) |
Procedural characteristics | |
 Number of interventions | 26 |
 Indication |  |
  TIPS placement* | 16 |
  TIPS revision | 2 |
  PVS | 5^ |
  VE | 3° |
 Splenic access success rate (successful / unsuccessful) | 26 / 0 |
 Interventional success rate (successful / unsuccessful) | 22 / 4 |
 Splenic access time (min) | 33 (10;133) |
 Total procedure time (min) | 208 (110;429) |
 Splenic access route (subcostal / intercostal) | 11 / 15 |
 Sheath size (F) | 4 (4;8) |
 No. of gelfoam cubes | 2 (1;5) |
 Clinical significant complications (no. of complications) | 4 |